UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The impact of genomic changes on treatment of lung cancer

American journal of respiratory and critical care medicine, 2013-10, Vol.188 (7), p.770-775, Article 770

2013

Volltextzugriff (PDF)

MET IHC Is a Poor Screen for MET Amplification or MET Exon 14 Mutations in Lung Adenocarcinomas: Data from a Tri-Institutional Cohort of the Lung Cancer Mutation Consortium

Journal of thoracic oncology, 2019-09, Vol.14 (9), p.1666-1671

2019

Volltextzugriff (PDF)

State of the art: Response assessment in lung cancer in the era of genomic medicine

Radiology, 2014-04, Vol.271 (1), p.6-27

2014

Volltextzugriff (PDF)

Dabrafenib in patients with BRAFV600E -positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial

The lancet oncology, 2016-05, Vol.17 (5), p.642-650

2016

Volltextzugriff (PDF)

Impact of TMB/PD-L1 expression and pneumonitis on chemoradiation and durvalumab response in stage III NSCLC

Nature communications, 2023-07, Vol.14 (1), p.4238-4238, Article 4238

2023

Volltextzugriff (PDF)

Smoking History as a Potential Predictor of Immune Checkpoint Inhibitor Efficacy in Metastatic Non-Small Cell Lung Cancer

JNCI : Journal of the National Cancer Institute, 2021-11, Vol.113 (12), p.1761-1769

2021

Volltextzugriff (PDF)

Clinical Definition of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2010-01, Vol.28 (2), p.357-360

2010

Volltextzugriff (PDF)

Biomarkers of Response to Epidermal Growth Factor Receptor Inhibitors in Non–Small-Cell Lung Cancer Working Group: Standardization for Use in the Clinical Trial Setting

Journal of clinical oncology, 2008-02, Vol.26 (6), p.983-994

2008

Volltextzugriff (PDF)

Assessment of Deep Natural Language Processing in Ascertaining Oncologic Outcomes From Radiology Reports

JAMA oncology, 2019-10, Vol.5 (10), p.1421

2019

Volltextzugriff (PDF)

Epidermal Growth Factor Receptor Mutations in Non–Small-Cell Lung Cancer: Implications for Treatment and Tumor Biology

Journal of clinical oncology, 2005-05, Vol.23 (14), p.3227-3234

2005

Volltextzugriff (PDF)

Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer

Nature communications, 2023-11, Vol.14 (1), p.7496-7496, Article 7496

2023

Volltextzugriff (PDF)

Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small Cell Lung Cancer

Clinical cancer research, 2009-12, Vol.15 (24), p.7502-7509

2009

Volltextzugriff (PDF)

Serological testing for SARS-CoV-2 antibodies of employees shows low transmission working in a cancer center

PloS one, 2022-04, Vol.17 (4), p.e0266791-e0266791

2022

Volltextzugriff (PDF)

Use of targeted next generation sequencing to characterize tumor mutational burden and efficacy of immune checkpoint inhibition in small cell lung cancer

Journal for immunotherapy of cancer, 2019-03, Vol.7 (1), p.87-87, Article 87

2019

Volltextzugriff (PDF)

Making Personalized Cancer Medicine a Reality: Challenges and Opportunities in the Development of Biomarkers and Companion Diagnostics

Clinical cancer research, 2012-02, Vol.18 (3), p.619-624

2012

Volltextzugriff (PDF)

Features of tumor-microenvironment images predict targeted therapy survival benefit in patients with EGFR-mutant lung cancer

The Journal of clinical investigation, 2023-01, Vol.133 (2), p.1-9

2023

Volltextzugriff (PDF)

Combined Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor (EGFR) Blockade Inhibits Tumor Growth in Xenograft Models of EGFR Inhibitor Resistance

Clinical cancer research, 2009-05, Vol.15 (10), p.3484-3494

2009

Volltextzugriff (PDF)

Author Correction: Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer

Nature communications, 2023-12, Vol.14 (1), p.8321-8321, Article 8321

2023

Volltextzugriff (PDF)

Adjuvant chemotherapy for surgically resected non–small cell lung cancer

The Journal of thoracic and cardiovascular surgery, 2012-09, Vol.144 (3), p.S39-S42

2012

Volltextzugriff (PDF)

ErbB-3 Mediates Phosphoinositide 3-Kinase Activity in Gefitinib-Sensitive Non-Small Cell Lung Cancer Cell Lines

Proceedings of the National Academy of Sciences - PNAS, 2005-03, Vol.102 (10), p.3788-3793

2005

Volltextzugriff (PDF)

The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies

Cancer cell, 2006-06, Vol.9 (6), p.485-495

2006

Volltextzugriff (PDF)

Defining comprehensive biomarker‐related testing and treatment practices for advanced non‐small‐cell lung cancer: Results of a survey of U.S. oncologists

Cancer medicine (Malden, MA), 2022-01, Vol.11 (2), p.530-538

2022

Volltextzugriff (PDF)

Effect of Epidermal Growth Factor Receptor Tyrosine Kinase Domain Mutations on the Outcome of Patients with Non–Small Cell Lung Cancer Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Clinical cancer research, 2006-07, Vol.12 (14), p.4416s-4420s

2006

Volltextzugriff (PDF)

1 – 25 von 1.999

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.690)
Mit Volltextzugriff
(1.705)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(982)
Life Sciences & Biomedicine
(749)
Humans
(508)
Biological And Medical Sciences
(336)
Medical Sciences
(228)
Physical Sciences
(177)
Animals
(163)
Oncology
(161)
Fundamental And Applied Biological Sciences. Psychology
(132)
Female
(112)
Technology
(92)
Chemistry
(70)
Science & Technology - Other Topics
(70)
Tumors
(69)
Social Sciences
(67)
Mutation
(64)
Pharmacology. Drug Treatments
(63)
General & Internal Medicine
(60)
Lung Cancer
(60)
Mice
(59)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(874)
Journals@Ovid Full Text
(701)
MEDLINE
(660)
Single Journals
(632)
IngentaConnect
(611)
Elsevier ScienceDirect Journals Complete
(303)
Wiley Journals
(271)
IngentaConnect Journals
(253)
Nexis Uni
(171)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(161)
JSTOR
(149)
Wiley Online Library Full Collection 2018
(141)
Oxford Journals Online Current
(125)
Nature Journals Online
(83)
SAGE Publications
(83)
SpringerLink Journals - AutoHoldings
(73)
Ebook Central Perpetual and DDA
(65)
Oxford Journals 2020 Medicine
(64)
eBooks on EBSCOhost
(62)
Taylor & Francis Online
(52)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(16)
... seit 30 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

The impact of genomic changes on treatment of lung cancer

Dabrafenib plus trametinib in patients with previously treated BRAFV600E -mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial

A single-cell landscape of high-grade serous ovarian cancer

MET IHC Is a Poor Screen for MET Amplification or MET Exon 14 Mutations in Lung Adenocarcinomas: Data from a Tri-Institutional Cohort of the Lung Cancer Mutation Consortium

State of the art: Response assessment in lung cancer in the era of genomic medicine

Dabrafenib in patients with BRAFV600E -positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial

Impact of TMB/PD-L1 expression and pneumonitis on chemoradiation and durvalumab response in stage III NSCLC

Smoking History as a Potential Predictor of Immune Checkpoint Inhibitor Efficacy in Metastatic Non-Small Cell Lung Cancer

Clinical Definition of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer

Biomarkers of Response to Epidermal Growth Factor Receptor Inhibitors in Non–Small-Cell Lung Cancer Working Group: Standardization for Use in the Clinical Trial Setting

Assessment of Deep Natural Language Processing in Ascertaining Oncologic Outcomes From Radiology Reports

Epidermal Growth Factor Receptor Mutations in Non–Small-Cell Lung Cancer: Implications for Treatment and Tumor Biology

Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer

Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small Cell Lung Cancer

Serological testing for SARS-CoV-2 antibodies of employees shows low transmission working in a cancer center

Use of targeted next generation sequencing to characterize tumor mutational burden and efficacy of immune checkpoint inhibition in small cell lung cancer

Making Personalized Cancer Medicine a Reality: Challenges and Opportunities in the Development of Biomarkers and Companion Diagnostics

Features of tumor-microenvironment images predict targeted therapy survival benefit in patients with EGFR-mutant lung cancer

Combined Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor (EGFR) Blockade Inhibits Tumor Growth in Xenograft Models of EGFR Inhibitor Resistance

Author Correction: Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer

Adjuvant chemotherapy for surgically resected non–small cell lung cancer

ErbB-3 Mediates Phosphoinositide 3-Kinase Activity in Gefitinib-Sensitive Non-Small Cell Lung Cancer Cell Lines

The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies

Defining comprehensive biomarker‐related testing and treatment practices for advanced non‐small‐cell lung cancer: Results of a survey of U.S. oncologists

Effect of Epidermal Growth Factor Receptor Tyrosine Kinase Domain Mutations on the Outcome of Patients with Non–Small Cell Lung Cancer Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Aktive Filter

Suchergebnisse filtern